Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014443
Status:
TERMINATED
Last Update Posted:
2023-01-09
First Post:
2001-04-10
Brief Title:
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Sponsor:
Rush University Medical Center
Organization:
Rush University Medical Center
Organization Data
Organization:
Rush University Medical Center
Class:
OTHER
Study ID:
CDR0000068544
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rush University Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None